To watch CK Clinical videos click here
CK Clinical is looking forward to exhibiting at the Nursing in Practice Conference which is taking place at the Bridgewater Hotel in Manchester on Tuesday 10th May 2011.
The Nursing in Practice Conference is specifically designed to meet the educational needs of primary care nurses and public health professionals. The programme will feature an impressive collection of speakers delivering highly topical and relevant presentations covering a number of issues, including:
- Drug and alcohol abuse
- Mental health and suicide
- Sexual health and youth
- Women’s health
- Updates on diabetes
This conference is completely free to attend, and even includes a free lunch! This conference is perfect for practice nurses, health visitors, community nurses, school nurses, healthcare assistants, midwifes, PCT nursing staff managers and district nurses. So if this sounds like you, why not register your place now by clicking here .
The Salford Lung Study
CK Clinical will be attending to speak specifically to those who are interested in getting involved with The Salford Lung Study. This study is an exciting and unique research project which will be focusing on asthma and COPD and is sponsored by GlaxoSmithKline. CK Clinical are exclusively recruiting for the large community study nurse team to drive this project, which will include:
If you would like further information before applying for one of these roles, please call us on 0114 283 9956 or email your CV to Salford@ckclinical.co.uk. To find out more about this exciting study, please click here.
Salford Lung Study Recruitment Briefing – Lunchtime Seminar
If you attending the Nursing in Practice conference you can find out more about The Salford Lung study by attending the lunchtime seminar which will take place from 12.55 to 13.25pm. The seminar will be presented by Dr Dave Leather, Medical Director GSK Respiratory Centre of Excellence.
You can also find out more by talking to one of the CK Clinical team at the conference. We will be exhibiting on stand number 17, so please come along and say hello. Alternatively, if you would like a confidential chat about the opportunities available to you within the Salford Lung Study, please email Ashley Kirk at email@example.com and he will be happy to schedule in an appointment for you.
BioCity is pleased to invite you to an event that will give you an opportunity to learn first-hand about the opportunities for European R&D funding in Healthcare projects soon to be announced in the 2012 FP7 call.This call has a significant focus on SMEs, with guaranteed EC funding to leading SME partners in successful consortia and a range of more broadly specified topics targeted at SME interests.
During the event there will also be an opportunity to hear about other sources of European Funding for SMEs through the Research for the Benefit of SMEs and Eureka Eurostars programs.
The event, organised in partnership with CK Science and Beta Technologies will also provide details on how to access further support , give attendees a chance to meet with national support teams, hear from a successful SME participant and network with potential partners. A buffet lunch will be provided.
When is the event?
This event will be taking place on Monday 23rd May at Biocity Nottingham’s Boardroom. The event will start at 9.00am and will finish at 13.30pm.
Who should attend?
The event is targeted at SMEs in the biotech/healthcare sector but will also be of interest to academics and other interested parties working in the following areas of health research;
• Detection and Diagnosis of disease
• Innovative therapeutic approaches and interventions
• Large scale data gathering and processing
• Development and ageing
• Translational research on major infectious diseases, including HIV, TB and malaria
• Translational research on, diabetes/obesity, rare and chronic diseases
• Healthcare systems and public health
• Adverse drug reactions
How to register?
To register your place at the event, or for more information, please contact Liam O’Connell at CK Science on 0114 283 9956 or email firstname.lastname@example.org.
CK Clinical are proud to announce that we will be exhibiting at the ICR 32nd Annual Conference on the 21st – 22nd March at the Brighton Hilton Metropole.
Here at CK Clinical we are big fans of the ICR Conference as it provides a great opportunity to not only learn about the latest developments in clinical research and but also to network with professionals in the area.
Our specialist Consultants Jim Gleeson and Ben Traies will be representing CK Clinical at the event. Please come and say hello, our stand number will be 35. If you would like to schedule in a meeting to discuss possible recruitment requirements or job opportunities, please email Jim at email@example.com.
We look forward to seeing you there!
CK Clinical’s sister company, CK Science will be featuring on the panel of experts for The Guardian’s Live Q&A discussing the skills physics graduates have gained – and the career options available to them.
Along with the other expert panel members, Director at CK Science, Ashley Kirk, will be offering insight into the types of jobs physics graduates can get into and the skills you will need to get them. With 20 years of experience in dealing with scientific careers, Ashley is well placed to provide some invaluable advice.
So if you have recently graduated in a Physics related degree or are looking for a new position in the area, why not join the discussion. It’s taking place tomorrow at 1-4pm. Please click here to find out more and to join the discussion tomorrow.
We look forward to seeing you there!
As reported by PharmaTimes, the UK-based pharmaceutical giant GlaxoSmithKline (GSK) has paid out $70 million for the Chinese drugmaker Nanjing MeiRui Pharmaceuticals, in an attempt to gain a stronger presence in China.
Nanjing MeiRui Pharmaceuticals is a leading Chinese Pharmaceutical entity and has a strong portfolio of mainly urology and allergy products. These include Prostat, a treatment for benign prostatic hyperplasia and Sheniting, a drug used for overactive bladder syndrome.
Under the deal, GSK will gain access to the Chinese company’s portfolio of products as well as benefitting from their already established sales and marketing platform, as well as a manufacturing facility based in Nanjing City.
Are you looking for a new position in the UK Pharmaceutical Industry? Click here to search our current pharmaceutical jobs online now.
Jeff Kindler, who has held the position of chief executive since 2006, stated that “the combination of meeting the requirements of our many stakeholders around the world and the 24/7 nature of my responsibilities, has made this period extremely demanding on me personally”.
It is planned that the head of Pfizer’s biopharmaceuticals business, Ian C Reed will be succeeding Mr Kindler.
Under Kindler’s stewardship, the pharmaceutical company shed more than 14,000 jobs, as well as closing manufacturing plants. The company also paid $68bn (£43bn) for rival Wyeth last year in an effort to invigorate its pipeline of new products.
Are you looking for a job in the UK Pharmaceutical Industry? Click here to search our current pharmaceutical jobs online now.
As reported by The Pharma Times, the global pharma company GlaxoSmithKline (GSK), has signed a deal with the Moscow-based JSC Binnopharm manufacture and sell a number of GSK’s cervical cancer, rotavirus and pneumococcal vaccines in its domestic market.
Under this agreement, GSK will be supplying all the ingredients, technology and expertise in order to make the vaccines while Binnopharm, a unit of oil-to-telecoms group Sistema, will put them together, and package and sell them in Russia.
The agreement covers the following vaccines:
- Cervarix – this protects againts HPV infections which cause cervical, head and neck cancers
- Rotarix – this protects against rotavirus which causes gastroenteritis and diarrhoea
- Synflorix – this protects against strains of Streptococcus pneumoniae that can cause illnesses such as pneumonia and meningitis.
Speaking of the agreement, the two firms stated, ‘The local manufacture of these vaccines should help Russia to modernise its National Immunisation Calendar in the future, adding additional vaccination against highly prevalent infections,’
‘This agreement is an example of the flexible approach we are taking to make innovative vaccines more available in emerging markets through local partnerships,’ said GSK’s head of emerging markets and Asia Pacific, Abbas Hussain.
Are you looking for a position in the UK pharmaceutical industry? Click here to search our current pharmaceutical jobs online now.
It has been announced that the Swiss pharmaceutical company Roche, plans to cut 6 per cent of their global workforce over the next 2 years. The pharmaceutical job cuts come in an effort by the pharma company to make annual costs savings totalling 2.4 billion Swiss Francs.
Speaking of the cost cutting initiative, CEO Severin Schwan stated it was designed to “to reinforce Roche’s long-term innovation capability in the face of increased price pressures and a more challenging market environment.”
The majority of the job cuts will hit the company’s pharmaceutical division and will ultimately lead to restructuring costs of approximately 2.7 billion. In addition, the sales and marketing workforce will be slashed by a total of 2650 positions, whilst several manufacturing sites in the US and Germany will be reorganised.
The development of preclinical research programmes will also be discontinued including that of cancer. However, the company will remain in its current therapeutic areas.
Are you looking for a new position in the Pharmaceutical industry? Click here to search our current pharmaceutical jobs online now.
If you’re not already on Linkedin, as a job-seeker looking for a new role in the Pharmaceutical industry you’re missing a trick.
Having a presence on Linkedin is essentially your chance to showcase your strengths, thus encouraging not only the right people, but also the right opportunities to come to you. The best way to do this is to create a great profile. Here are some tips to tips help you create a profile that will stand out from the crowd.
Once you have created your profile, why not become part of the CK Clinical community by joining our Linkedin Group.
By joining our group you will have instant access to our latest pharmaceutical job opportunities, industry news and careers advice. Not only this, but you will be able to keep in contact and chat with other job-seekers in your position!